Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation
A completed clinical trial evaluated a 360-degree intra-procedural display to assist percutaneous liver tumor ablation, assessing its potent…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: TACE With Immune Agents for Angiogenesis in Hepatocellular Carcinoma [NA]
A completed clinical trial evaluating transarterial chemoembolization with immune agents to target angiogenesis in hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors [Phase 1]
Phase 1 trial update from Mayo Clinic evaluating a viral therapy for refractory liver cancer and other advanced solid tumors. The study (NCT…
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Effectiveness of Trans-Arterial Chemo Embolization for Hepatocellular Carcinoma on Follow-Up CT Triphasic Liver
This clinical trial update reports on the effectiveness of trans-arterial chemoembolization for hepatocellular carcinoma based on follow-up …
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma [Phase 2]
Phase 2 clinical trial evaluating JS207 in combination with JS007 as first-line therapy for advanced hepatocellular carcinoma is currently r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203) [Phase 2]
This is a Phase 2 master protocol evaluating SAR444245 in combination with other anticancer therapies for several gastrointestinal cancers; …
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating MIV-818 in liver cancer manifestations (hepatocellular carcinoma and intrahepatic cholangioc…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: To Evaluate the Safety and Efficacy of Microwave Ablation Therapy in Patients With Primary Liver Cancer [NA]
A clinical trial evaluating microwave ablation therapy for hepatocellular carcinoma has been terminated; no results are provided in the upda…
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma
Tongji Hospital's clinical trial NCT07030842 on precision recurrence risk assessment in early-stage hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: The Treatment of Bioartificial Liver With hiHep Cells After Extensive Hepatectomy [EARLY_Phase 1]
An early-phase (Phase 1) clinical trial is recruiting to evaluate a bioartificial liver therapy using hiHep cells in patients after extensiv…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: International Study of High-Risk Patients for Hepatocellular Carcinoma Using Liquid Biopsy
A Johns Hopkins University–sponsored international trial evaluating liquid biopsy to detect hepatocellular carcinoma in high-risk patients w…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Phase II Study of PRL3-ZUMAB in Advanced Solid Tumors [Phase 2]
Phase II clinical trial of PRL3-ZUMAB in advanced solid tumors is currently recruiting, with planned investigations in gastric cancer and he…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence [NA]
A multicenter prospective trial is evaluating perioperative finotonlimab in combination with bevacizumab for patients with resectable hepato…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: KAT-101 in Subjects With Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]
A Phase 1/2 trial of KAT-101 for hepatocellular carcinoma and fibrolamellar carcinoma has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma [Phase 1]
A Phase 1 clinical trial update for CT-01 in intermediate or advanced hepatocellular carcinoma shows the study is currently NOT_YET_RECRUITI…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: PD-1 Inhibitor Combined With 125I Seed Implantation for Hepatocellular Carcinoma's Extrahepatic Metastasis: Efficacy and Safety [NA]
A completed clinical trial evaluated a PD-1 inhibitor in combination with 125I seed implantation for hepatocellular carcinoma with extrahepa…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC [Phase 2]
Phase II trial evaluating concurrent nivolumab with external beam radiation therapy in advanced hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC [Phase 2]
This update describes a Phase II trial comparing AK104 in combination with lenvatinib versus lenvatinib alone for second-line hepatocellular…
-
CLINICAL_TRIALS trial_result · 2025-05-21Clinical Trial Update: Domvanalimab and Zimberelimab in Advanced Liver Cancers [Phase 2]
Phase 2 trial update examining domvanalimab and zimberelimab in advanced liver cancers, including cholangiocarcinoma and hepatocellular carc…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: Efficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCC
Clinical trial results report the efficacy of combining Target immunotherapy with XELOX chemotherapy in advanced hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis [NA]
A completed clinical trial evaluating contrast-enhanced ultrasound imaging for diagnosing hepatocellular carcinoma in patients with liver ci…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating atezolizumab and bevacizumab with photon radiotherapy for unresectable hepatocellular carcinoma is currently recrui…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma
This real-world study evaluates the combination of camrelizumab and apatinib mesylate for unresectable hepatocellular carcinoma and is curre…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy [Phase 3]
Phase 3 trial of atezolizumab plus bevacizumab for unresectable or locoregionally unsuitable hepatocellular carcinoma in Spanish patients ha…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy [Phase 1, Phase 2]
Clinical trial update on safety and efficacy of investigational therapy NMS-01940153E in adults with unresectable hepatocellular carcinoma w…